Drug-induced Immune Thrombocytopenia

被引：24
|
作者：
Chong, Beng H. [1 ,2 ]
Choi, Philip Young-Ill [2 ,3 ]
Khachigian, Levon [3 ]
Perdomo, Jose [2 ,3 ]
机构：
[1] St George Hosp, Dept Haematol, Kogarah, NSW 2217, Australia
[2] Univ New S Wales, St George Hosp, Dept Med, St George Clin Sch, Kogarah, NSW 2217, Australia
[3] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2033, Australia
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2013年 / 27卷 / 03期
关键词：
Drugs; Thrombocytopenia; Immune; Antibodies; QUININE-INDUCED THROMBOCYTOPENIA; HEPARIN-INDUCED THROMBOCYTOPENIA; PLATELET GLYCOPROTEIN IIB/IIIA; DEPENDENT ANTIBODIES; PROFOUND THROMBOCYTOPENIA; IN-VITRO; ANTIPLATELET ANTIBODIES; NONCYTOTOXIC DRUGS; NOD/SCID MOUSE; BINDING-SITE;
D O I：
10.1016/j.hoc.2013.02.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Thrombocytopenia is caused by immune reactions elicited by diverse drugs in clinical practice. The activity of the drug-dependent antibodies produces a marked decrease in blood platelets and a risk of serious bleeding. Understanding of the cellular mechanisms that drive drug-induced thrombocytopenia has advanced recently but there is still a need for improved laboratory tests and treatment options. This article provides an overview of the different types of drug-induced thrombocytopenia, discusses potential pathologic mechanisms, and considers diagnostic methods and treatment options.
引用
收藏
页码：521 / +
页数：21
相关论文
共 50 条
  • [31] Recommendations for standardization of laboratory testing for drug-induced immune thrombocytopenia: communication from the SSC of the ISTH
    Arnold, D. M.
    Curtis, B. R.
    Bakchoul, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (04) : 676 - 678
  • [32] Treatment of drug-induced immune thrombocytopenias
    Marini, Irene
    Uzun, Gunalp
    Jamal, Kinan
    Bakchoul, Tamam
    HAEMATOLOGICA, 2022, 107 (06) : 1264 - 1277
  • [33] Drug-Induced Thrombocytopenia An Updated Systematic Review, 2010
    Nguyen, Long
    Reese, Jessica
    George, James N.
    DRUG SAFETY, 2011, 34 (05) : 437 - 438
  • [34] Drug-induced thrombocytopenia - An updated systematic review, 2006
    Li, Xiaoning
    Swisher, Karen K.
    Vesely, Sara K.
    George, James N.
    DRUG SAFETY, 2007, 30 (02) : 185 - 186
  • [35] Is interleukin 3 active in anticancer drug-induced thrombocytopenia?
    Newland, AC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 : S83 - S88
  • [36] Comment on “Drug-Induced Thrombocytopenia: An Updated Systematic Review”
    Bart L. De Keulenaer
    Chan Y. Cheah
    Drug Safety, 2009, 32 : 707 - 707
  • [37] Drug-Induced Thrombocytopenia An Updated Systematic Review, 2008
    Swisher, Karen K.
    Li, Xiaoning
    Vesely, Sara K.
    George, James N.
    DRUG SAFETY, 2009, 32 (01) : 85 - 86
  • [38] Rare complication of ceftriaxone therapy: drug-induced thrombocytopenia (DITP)
    Sharma, Aishwarya
    Mannuru, Devendranath
    Matta, Abhishek
    Kaushal, Amit
    BMJ CASE REPORTS, 2021, 14 (09)
  • [39] Drug-induced thrombocytopenia in a patient with colorectal cancer: A case report
    Pasquariello, Stefano
    Clavarezza, Matteo
    Piredda, Sabrina
    Foppiani, Luca
    Pesce, Giampaola
    Antonucci, Giancarlo
    De Censi, Andrea
    Mattioli, Francesca
    ONCOLOGY LETTERS, 2023, 26 (03)
  • [40] Cross-reactivity between piperacillin-tazobactam and cefoperazone-sulbactam in drug-induced immune thrombocytopenia
    He, Xiaoyan
    Huang, Wanting
    Wan, Xiong
    Li, Xiaoya
    Chang, Qiuhong
    Ding, Ling
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (03)
12345